Some Investing Thoughts On AbCellera Biologics Inc (NASDAQ: ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.42, with 4.05 million shares of worth about $9.8 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.60% during that period and on June 04, 2025 the price saw a […]
Reviewing The Case For AbCellera Biologics Inc (ABCL) Going Higher
Currently, there are 298.36M common shares owned by the public and among those 223.95M shares have been available to trade. The company’s stock has a 5-day price change of 3.45% and -28.81% over the past three months. ABCL shares are trading -28.33% year to date (YTD), with the 12-month market performance down to -46.84% lower. […]
Analysts Update Their Price Forecasts For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.49, with 3.45 million shares of worth about $8.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.84% during that period and on May 01, 2025 the price saw a […]
Tomorrow Is Not Likely To Be Same For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.53, with 4.43 million shares of worth about $11.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.85% during that period and on April 23, 2025 the price saw a […]